Investigating Participation Patterns Among Stage IV Melanoma Patients

Launched by POWER LIFE SCIENCES INC. · Oct 16, 2023

Keywords

ClinConnect Summary

This clinical trial is looking into how patients with stage IV melanoma participate in research studies. The main goal is to understand how many patients complete the trial and how many choose to leave before it's over. This information is important because it helps researchers learn about new treatments for melanoma and see if they are better than the standard ones currently available.

To be eligible for the trial, you need to be at least 18 years old and diagnosed with stage IV melanoma. It’s also important that you can understand the study and give your consent to participate. However, if you are pregnant or nursing, or if you have certain mental health issues that might make it hard for you to take part, you won't be able to join. If you do participate, you can expect to provide feedback about your experience throughout the trial, which will help contribute to the development of new treatment options for melanoma.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥ 18 years old
• • Diagnosis of stage IV melanoma
• • Able to comprehend the investigational nature of the protocol and provide informed consent
• Exclusion Criteria:
• • Female patients who are currently pregnant or nursing
• • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
• • Inability to perform regular electronic reporting